Vijaya Diagnostic Centre per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹18.23₹16.81₹13.95₹11.62₹8.29
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹18.19₹16.79₹13.92₹11.59₹8.26
₹93.02₹93.02₹77.53₹64.21₹53.37
₹83.30₹79.13₹66.39₹53.52₹44.99
—₹26.30₹21.87₹17.91₹16.13
₹8.54₹8.54₹12.56₹9.32₹3.90
—₹2.00₹1.00₹1.00₹1.00
10.310.310.310.210.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIJAYA₹1,464.20

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹15,066 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS8.2911.6213.9516.8118.23
Diluted EPS8.2611.5913.9216.7918.19
Book Value per Share53.3764.2177.5393.0293.02
Revenue per Share44.9953.5266.3979.1383.30
Cash Flow per Share16.1317.9121.8726.30—
Free Cash Flow per Share3.909.3212.568.548.54
Dividends per Share1.001.001.002.00—
Shares Outstanding (cr)10.210.210.310.310.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.